UWA Logo What's On at UWA
   UWA HomeProspective Students  | Current Students  | Staff  | Alumni  | Visitors  | About  |     Search UWA    for      

SEMINAR: 'How to generate research funding by leveraging your IP'

* Login to add events... *
Today's date is Saturday, July 24, 2021
'How to generate research funding by leveraging your IP' Other events...
Dr Samantha South is a Life Sciences technology transfer manager in the Research Development & Innovation (RDI) office at UWA. She has a PhD in behavioural pharmacology and an extensive background in medical research which includes working at Cornell University (NY), The University of Queensland and The Garvan Institute (UNSW). She has previously been involved in managing honours and PhD students, writing journal articles and involved with journal review panels and the scientific advisory committee of the Australian Pain Society. She was the preclinical manager at TetraQ, a preclinical contract organization specializing in providing preclinical drug development services to the pharmaceutical, biotechnology and complementary medicine industries. This included contract research efficacy and pharmacokinetics assessment, development and validation of animal models of disease, managing an animal facility and participating on animal ethics committees. As such, she has extensive experience with commercial preclinical drug development strategies, regulatory milestones, and performance criteria (commercial go/no-go).

Samantha has an MBA and many years' experience in the technology transfer/biotech sector which includes the assessment and valuation of new technologies, devising IP protection strategies, managing out-licensing/partnering activities, raising investment into managing new start-up companies, research and licensing deals with a wide range of clients including Universities, SMEs, multinationals, state and federal governments. She is also currently involved on NHMRC development grant review panels and is the UWA nominee Director on new UWA spin-out companies, MiReven (miR-7 therapy) and Eridan (nanoparticle delivery).
Speaker(s) Dr Samantha South
Location Seminar Room G24, Harry Perkins Institute of Medical Research, Ground Floor, QQ Block, SCGH, 6 Verdun Street Nedlands 6009
Contact Fiona Mackenzie <[email protected]> : 61510700
URL http://www.perkins.org.au
Start Thu, 26 Feb 2015 12:00
End Thu, 26 Feb 2015 13:00
Submitted by Fiona Mackenzie <[email protected]>
Last Updated Thu, 12 Feb 2015 15:53
Included in the following Calendars:
Additional Information:
  • Locations of venues on the Crawley and Nedlands campuses are available via the Campus Maps website.
  • Download this event as: Text | iCalendar
  • Mail this event:

Top of Page
© 2001-2010  The University of Western Australia
Questions? Mail [email protected]